Showing 271-280 of 2040 results for "".
Physician Spotlight: Mark D. Kaufmann, MD and Neal Bhatia, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-mark-d-kaufmann-md-and-neal-bhatia-md/23299/What’s Old is New: Cosmetic Trends for 2020
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-old-is-new-cosmetic-trends-for-2020/23193/Experts go back to basics for best results.Type Casting: Assessing Personality Before a Hire
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/type-casting-assessing-personality-before-a-hire/22994/Can the Myers–Briggs Type Indicator take the guess work out of your next hiring decision?CSF After Dark
https://practicaldermatology.com/topics/practice-management/csf-after-dark/20404/What happens in Vegas stays in Vegas. Or does it?From the Neck Down
https://practicaldermatology.com/topics/practice-management/from-the-neck-down/20781/Exploring other uses for Allergan's KybellaMedical Credentialing
https://practicaldermatology.com/topics/practice-management/medical-credentialing/20948/You can help distinguish yourself from the masses by highlighting the unique credentials of your team.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21777/Overcoming Real and Perceived Challenges in Medical Management of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/overcoming-real-and-perceived-challenges-in-medical-management-of-actinic-keratoses/21845/Everyone from prescribers to patients to pharmacists plays a role in the successful incorporation of medical AK management.Stoking the Embers: Re-exploring Topical Coal Products
https://practicaldermatology.com/columns/clinical-focus-1/stoking-the-embers-re-exploring-topical-coal-products/23825/The Role of GLP-1RAs in Treating Inflammatory Dermatologic Diseases
https://practicaldermatology.com/issues/novemberdecember-2025/the-role-of-glp-1ras-in-treating-inflammatory-dermatologic-diseases/48899/Herein, we review the benefits and risks of GLP-1RAs with a focus on these 3 chronic inflammatory conditions.